/
Experimental Design Hemizygous animals from stock 5493 were separated into 3 groups: Experimental Design Hemizygous animals from stock 5493 were separated into 3 groups:

Experimental Design Hemizygous animals from stock 5493 were separated into 3 groups: - PowerPoint Presentation

amelia
amelia . @amelia
Follow
27 views
Uploaded On 2024-02-09

Experimental Design Hemizygous animals from stock 5493 were separated into 3 groups: - PPT Presentation

No Doxycycline Supplementation Doxycycline in MediGel at 2mgml Doxycycline in Acidified 10 Sucrose Drinking Water Animals were given supplementation in home cage environment for 7 days Animals were sacrificed after 7 days and heart and kidney were stained for ID: 1045909

heart expression transgene dox expression heart dox transgene reporter doxycycline gal stock tetracycline kidney treatment observed lung vascular endothelium

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Experimental Design Hemizygous animals f..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

1. Experimental DesignHemizygous animals from stock 5493 were separated into 3 groups:No Doxycycline SupplementationDoxycycline in MediGel at 2mg/mlDoxycycline in Acidified 10% Sucrose Drinking WaterAnimals were given supplementation in home cage environment for 7 daysAnimals were sacrificed after 7 days and heart and kidney were stained for β-gal activity

2. MediGelTM Assisted Doxycycline Administration in a Tet Inducible Reporter Mouse

3. STOCK Tg(Tek-rtTA,TRE-lacZ)1425Tpr/J; Jax Stock 005493Fig. 4. Histological analysis of Dox-induced reporter transgene expression in the microvasculature. Tissue samples following X-Gal staining were paraffin embedded, sectioned, and counterstained with Nuclear Fast Red. A: in the heart, reporter transgene expression is uniformly seen in the endocardium in both ventricles and over the tricuspid valves. B–D: small vessels and microvessels express the transgene in the cerebrum (B), lung (C), and within cardiac muscle (D). E: renal expression of the transgene in the afferent arteriole and glomerular capillaries. Note: because of the nuclear localization of the reporter ßGal, only endothelial cells whose nuclei are contained within the section are visualized.In the presence of tetracycline or a tetracycline analog (such as doxycycline), selective expression of beta-galactosidase is observed in the nuclei of vascular endothelium in a wide variety of tissues (aorta, heart, brain, lung, kidney, liver, spleen, uterus, prostate, stomach, skeletal muscle, large and small intestine). Expression is observed as early as embryonic day 9.5. In the absence of tetracycline, some beta-galactosidase expression occurs in the smaller branches of the aorta.Physiol Genomics. 2002 Oct 29;11(2):99-107. Inducible and selective transgene expression in murine vascular endothelium.Teng PI, Dichiara MR, Kömüves LG, Abe K, Quertermous T, Topper JN.

4. No Dox TreatmentDOX Medigel Treatment Heart 20XMedigel supplemented with doxycycline demonstrates a more uniform expression pattern.

5. DOX H2O Treatment Heart 20X

6. No Dox Treatment Heart 20X

7. No Dox treatmentDox gel kidneyDox H20 kidney